These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15719556)

  • 41. Cybernetic modeling of the cephalosporin C fermentation process by Cephalosporium acremonium.
    Kim BM; Kim SW; Yang DR
    Biotechnol Lett; 2003 Apr; 25(8):611-6. PubMed ID: 12882154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Review of in vitro activity of third-generation cephalosporins and other newer beta-lactam antibiotics against clinically important bacteria.
    Thornsberry C
    Am J Med; 1985 Aug; 79(2A):14-20. PubMed ID: 3927723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Industrial production of beta-lactam antibiotics.
    Elander RP
    Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):385-92. PubMed ID: 12679848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Functional characteristic of the CefT transporter of the MFS family involved in the transportation of beta-lactam antibiotics in Acremonium chrysogenum and Saccharomyces cerevisiae].
    Dumina MV; Zhgun AA; Kerpichnikov IV; Domracheva AG; Novak MI; Valiakhmetov AIa; Knorre DA; Severin FF; Él'darov MA; Bartoshevich IuÉ
    Prikl Biokhim Mikrobiol; 2013; 49(4):372-81. PubMed ID: 24455863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Research progress on strain improvement of Acremonium chrysogenum by genetic engineering].
    Hu YJ; Zhu BQ
    Yi Chuan; 2011 Oct; 33(10):1079-86. PubMed ID: 21993282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RIT 2214, a new biosynthetic penicillin produced by a mutant of Cephalosporium acremonium.
    Troonen H; Roelants P; Boon B
    J Antibiot (Tokyo); 1976 Dec; 29(12):1258-67. PubMed ID: 1034629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative metabolic flux analysis revealed uneconomical utilization of ATP and NADPH in Acremonium chrysogenum fed with soybean oil.
    Li J; Yang Y; Chu J; Huang M; Li L; Zhang X; Wang Y; Zhuang Y; Zhang S
    Bioprocess Biosyst Eng; 2010 Nov; 33(9):1119-29. PubMed ID: 20571830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative analysis of intracellular metabolites of Cephalosporium acremonium in pilot and industrial fermentation processes.
    Yang Y; Lu H; Ding MZ; Jiang J; Chen Y; Yuan YJ
    Biotechnol Appl Biochem; 2012; 59(3):228-37. PubMed ID: 23586833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A GATA-type transcription factor AcAREB for nitrogen metabolism is involved in regulation of cephalosporin biosynthesis in Acremonium chrysogenum.
    Guan F; Pan Y; Li J; Liu G
    Sci China Life Sci; 2017 Sep; 60(9):958-967. PubMed ID: 28812298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cephalosporins: rationale for clinical use.
    Molavi A
    Am Fam Physician; 1991 Mar; 43(3):937-48. PubMed ID: 2000736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cephalosporins in clinical development.
    Page MG
    Expert Opin Investig Drugs; 2004 Aug; 13(8):973-85. PubMed ID: 15268635
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Environmentally safe production of 7-ACA by recombinant Acremonium chrysogenum.
    Liu Y; Gong G; Zhu C; Zhu B; Hu Y
    Curr Microbiol; 2010 Dec; 61(6):609-14. PubMed ID: 20454963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The selection and use of cephalosporins: a review.
    Klein NC; Cunha BA
    Adv Ther; 1995; 12(2):83-101. PubMed ID: 10150326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study Group.
    Biedenbach DJ; Johnson DM; Jones RN
    Diagn Microbiol Infect Dis; 1999 Dec; 35(4):325-31. PubMed ID: 10668592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro evaluation of broad-spectrum beta-lactams in the philippines medical centers: role of fourth-generation cephalosporins. The Philippines Antimicrobial Resistance Study Group.
    Johnson DM; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 1999 Dec; 35(4):291-7. PubMed ID: 10668588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fourth generation cephalosporins in the antimicrobial chemotherapy of surgical infections.
    Giamarellou H
    J Chemother; 1999 Dec; 11(6):486-93. PubMed ID: 10678790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of cephalosporin C production by cultivation of Cephalosporium acremonium M25 using a mixture of inocula.
    Lee MS; Lim JS; Kim CH; Oh KK; Yang DR; Kim SW
    Lett Appl Microbiol; 2001 Jun; 32(6):402-6. PubMed ID: 11412352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the secondary metabolites in two scales of cephalosporin C (CPC) fermentation and two different post-treatment processes.
    Cao YX; Lu H; Qiao B; Chen Y; Yuan YJ
    J Ind Microbiol Biotechnol; 2013 Jan; 40(1):95-103. PubMed ID: 23053347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.